Understanding the Clinical Effects and Mechanisms of Action of Neurosteroids

Dr. Schatzberg has served as a consultant to Alkermes, Axsome, Bracket, Compass, Delpor, Epiodyne, Janssen, Jazz, Lundbeck/Takeda, McKinsey, Myriad Genetics, NeuraWell, Neuronetics, Otsuka, Sage, Schwabe, Signant, Tris, Vorso, and Owl Analytics; he has equity in Corcept (cofounder), Delpor, Epiodyne, Gilead, Incyte, Intersect ENT, Merck, Owl Analytics, Seattle Genetics, Titan, Vorso, and Xhale; and he is named as an inventor on patents on the use of pharmacogenetics and antiglucocorticoids to predict antidepressant response. Dr. Kleinman reports no financial relationships with commercial interests.